Regulatory Guidance forDeveloping Technologies.

Our attorneys bring deep healthcare and FDA regulatory knowledge to the questions that arise as technology reshapes how care is delivered, how health data moves, and how products reach the market.

The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.

For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.

Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.

Read More About Us

Quick Links

Wilson Sonsini secured a jury trial win for Google in a case alleging misuse of advertising technology.

Click for additional details.

Careers

We look for the best and brightest of tomorrow and develop careers from the ground up.

News and Featured Insights

News Articles

Wilson Sonsini Attorneys Appointed to American Bar Association Leadership Roles

News Articles

The National Law Journal Names Wilson Sonsini 2026 “Appellate Hot List” Finalist

Alerts

Seismic and Highspot Obtain Merger Clearance After Targeted Review Shows Rising Competition from AI in Sales Enablement Software

Leading Matters

Client Highlights

Firm Advises Mara on $7 Million Funding Round

On August 26, 2026, Mara, a defense hardware start-up, announced a $7 million funding round to bring Spike, its integrated counter-UAS platform designed for the small, inexpensive FPV drones reshaping modern conflict, from field testing to broad combat deployment. The round was led by Khosla Ventures, with participation from a16z Speedrun, Night Capital, Palmdrive, Protagonist, Freedom Fund, and Indicator Fund, alongside angel investors. Wilson Sonsini Goodrich & Rosati advised Mara on the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises Altruist on Acquisition by Vanguard

On August 26, 2026, Vanguard and Altruist, an AI-forward wealth technology and custody platform serving financial advisors, announced that they have entered into a definitive agreement under which Vanguard will acquire Altruist. Wilson Sonsini Goodrich & Rosati is advising Altruist on the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises Checkr on Acquisition of Truv

On August 18, 2026, Checkr, an AI-powered verification platform for high-stakes decisions, announced the acquisition of Truv, a consumer-permissioned income, employment, and asset verification company. Wilson Sonsini Goodrich & Rosati advised Checkr on the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises Highspot on Merger with Seismic

On August 18, 2026, Seismic, an AI-powered sales and revenue enablement platform, announced the completion of its merger with Highspot. Following a second request review, the merger obtained U.S. antitrust clearance, which allowed the transaction to close without any action by the Department of Justice Antitrust Division. The combined company will operate under the Seismic name and be led by Seismic Chief Executive Officer Rob Tarkoff. Wilson Sonsini Goodrich & Rosati advised Highspot on the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises InduPro on $77 Million Series B Financing

On August 12, 2026, InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, announced the closing of a $77 million Series B financing led by The Column Group, with participation from Vida Ventures, MRL Ventures Fund, Emerson Collective (advised by Yosemite), Euclidean Capital, Solasta Ventures, Sanofi, and Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised InduPro on the transaction.

Learn More

Client Highlights

Firm Advises Gravis Robotics on $200 Million Series A

On August 17, 2026, Gravis Robotics, a company retrofitting construction machines with autonomous technology, announced their Series A financing, with SoftBank investing $200 million in the company. The funding is the largest Series A in construction robotics history and will be used to scale autonomous machinery, bringing physical artificial intelligence (AI) directly to construction sites and embedding autonomous systems into heavy machinery fleets. Wilson Sonsini Goodrich & Rosati advised Gravis on the transaction.

Learn More

See More Leading Matters

The Life Sciences Report – June 2026

This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.